top of page
Budesonide Te Arai controlled-release capsules is indicated for the treatment of Crohn's disease. (1)
​
Budesonide Te Arai is Fully funded from 1 November 2023. (2)
Te Arai BioFarma is proud to be the first generic budesonide 3mg medicine to be funded in New Zealand.
​
For product information please visit below
​
1. Medsafe Datasheet. 2. PHARMAC funding notification
​
bottom of page